Janus kinase inhibitors for atopic dermatitis: a promising treatment modality-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Janus kinase inhibitors for atopic dermatitis: a promising treatment modality

Published:2021-02-28 Issue:5 Volume:46 Page:820-824
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:Clin Exp Dermatol

Author:

Cartron A. M.¹,Nguyen T. H.¹,Roh Y. S.²,Kwatra M. M.³,Kwatra S. G.²^ORCID

Affiliation:

1. Department of Dermatology University of Maryland School of Medicine Baltimore MD USA

2. Department of Dermatology Johns Hopkins University School of Medicine Baltimore MD USA

3. Department of Anesthesiology Duke University Medical Center Durham NC USA

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ced.14567

Reference30 articles.

1. Guidelines of care for the management of atopic dermatitis

2. Atopic dermatitis

3. Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: A systematic review and meta-analysis

4. Psychological Consequences of the Most Common Dermatoses: Data from the Objectifs Peau Study

5. Adult eczema prevalence and associations with asthma and other health and demographic factors: A US population–based study

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin-1α inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studies;Archives of Dermatological Research;2024-08-30

2. Atopic Dermatitis and Abrocitinib: Unraveling the Therapeutic Potential;Current Signal Transduction Therapy;2024-07

3. SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation;Frontiers in Immunology;2024-06-21

4. Abrocitinib may improve itch and quality of life in patients with itch‐dominant atopic dermatitis;Skin Health and Disease;2024-05-05

5. A Case of Livedoid Vasculopathy Treated with Abroctinib and Literature Review;Advances in Clinical Medicine;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3